Factors affecting cardiolipin antibody assays: Modification with polyethylene glycol compound

British Journal of Haematology

Volumn 100, Issue 1, 1998, Pages 52-57

  Kilpatrick, David C ^a,b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b Academic Unit   (United Kingdom)

Author keywords

2 glycoprotein 1; Anti cardiolipin antibodies; Anti phospholipid antibodies; Anti phospholipid syndrome; Polyethylene glycol compound

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; MACROGOL;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PLASMA; PRIORITY JOURNAL;

ANTIBODIES, ANTICARDIOLIPIN; BETA 2-GLYCOPROTEIN I; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HEAT; HUMANS; POLYETHYLENE GLYCOLS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0031983157     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00532.x     Document Type: Article

References (15)

1. 2-glycoprotein-1 in patients with primary antiphospholipid syndrome. Journal of Rheumatology, 22, 1894-1898.
2. Galli, M., Comfurius, P., Maassen, C., Hemker, H.C., De Baets, M.H., Van Breda-Vriesman, P.J.C., Barbui, T., Zwaal, R.F.A. & Bevers, E.M. (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 335, 1544-1547.
3. Harris, E.N. (1995) Phospholipid binding antibodies warrant continued investigation. Blood, 85, 2276-2277.
4. Harris, E.N., Gharavi, A.E., Patel, S.P. & Hughes, G.R.U. (1987) Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4th April. 1986. Clinical and Experimental Immunology, 68, 215-222.
5. Hughes, J.R., Davies, J.A. & Prentice, C.R.M. (1996) The effect of different microtitre plates on the enzyme-linked immunosorbent assay (ELISA) for anticardiolipin antibodies (ACAs). Thrombosis Research, 84, 217-222.
6. Loizou, S., McCrea, J.D., Rudge, A.C., Reynolds, R., Boyle, C.C. & Harris, E.N. (1985) Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clinical and Experimental Immunology, 62, 738-745
7. 2-glycoprotein 1 structure altered by interacting with an oxygen modified solid phase surface. Journal of Experimental Medicine, 179, 457-462.
8. McNeil, H.P., Chesterman, C.N. & Krilis, S.A. (1991) Immunology and clinical importance of antiphospholipid antibodies. Advances in Immunology, 49, 193-280.
9. Menon, S., Rahman, M.A.A., Ravirajan, C.T., Kandiah, D., Longhurst, C.M., McNally, T., Williams, W.M., Latchman, D.S. & Isenberg, D.A. (1997) The production, binding characteristics and sequence analysis of four human monoclonal antiphospholipid antibodies. Journal of Autoimmunity, 10, 43-47.
10. Panton, J.A. & Kilpatrick, D.C. (1997a) Anti-cardiolipin antibodies in sexual partners of recurrent aborters. Human Reproduction, 12, 464-467.
11. Panton, J.A. & Kilpatrick, D.C. (1997b) Anti-cardiolipin antibodies in blood donors. Biochemical Society Transactions, 25, 320S.
12. Reber, G., Arvieux, J., Comby, E., Degenne, D., de Moerloose, P., Sanmarco, M. & Potron, G. (1995) Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. Thrombosis and Haemostasis, 73, 444-452.
13. Shapiro, S.S. (1996) The lupus anticoagulant/antiphospholipid syndrome. Annual Review of Medicine, 47, 533-553.
14. 2-GP1 are two distinct populations of autoantibodies. Thrombosis and Haemostasis, 75, 303-308.
15. 2-glycoprotein I in anti-cardiolipin calibrators. Clinical Chemistry, 42, 642-643.